Activation of the CaSR in breast cancer cells have also been shown to stimulate cell proliferation acting through membrane metalloproteinases, upregulating the transient receptor potential channel 1, stimulating EGFR, and ERK1/2 phosphorylation (82, 83). Here, EGFR is linked to breast carcinoma.